Introduction
The global Hepatitis E diagnostic tests market is witnessing significant growth, driven by the increasing prevalence of Hepatitis E virus (HEV) infections, advancements in diagnostic technologies, and the rising demand for point-of-care testing solutions. Hepatitis E, primarily transmitted through contaminated water, poses a substantial public health challenge, particularly in regions with limited sanitation and healthcare infrastructure.
Market Overview
Global Hepatitis E Diagnostic Tests Market size and share is currently valued at USD 54.61 million in 2024 and is anticipated to generate an estimated revenue of USD 78.62 million by 2032, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 4.6% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2024 – 2032
Key Companies
- Abbott Laboratories
- F. Hoffmann-La Roche Ltd
- Siemens Healthineers
- Bio-Rad Laboratories
- Thermo Fisher Scientific
- DiaSorin S.p.A.
- Perkin Elmer Inc.
- QIAGEN N.V.
- bioMérieux SA
- Merck KGaA
- Ortho Clinical Diagnostics
Regional Analysis
1. Asia Pacific
Asia Pacific dominates the global Hepatitis E diagnostic tests market, accounting for 36.9% of the revenue share in 2024 . Countries like India, China, and Bangladesh report high incidences of HEV infections, primarily due to inadequate sanitation and contaminated water sources. In India, approximately 60% of blood donors have circulating anti-HEV IgG antibodies, indicating widespread exposure to the virus . The Indian market is expected to grow at a CAGR of 6.6% from 2025 to 2030, reaching USD 7.1 million by 2030 .
2. North America
In North America, the prevalence of HEV is relatively low; however, the region is witnessing an increase in imported cases due to travel and migration. Diagnostic testing is primarily focused on individuals with unexplained liver abnormalities or those returning from endemic areas. The integration of HEV testing into routine diagnostic panels is becoming more common, supported by advancements in PCR and ELISA technologies .
3. Europe
Europe reports sporadic outbreaks of HEV, often associated with undercooked pork consumption. Countries like Germany, France, and the UK have implemented robust surveillance systems to monitor and control HEV infections. The European market benefits from strong regulatory frameworks and public-private partnerships aimed at enhancing diagnostic capabilities .
4. Middle East & Africa
In the Middle East, countries like Saudi Arabia and the UAE are observing a gradual increase in HEV cases. The Saudi Arabian market generated USD 1.4 million in 2024 and is projected to reach USD 1.6 million by 2030, growing at a CAGR of 2.5% . In Sub-Saharan Africa, HEV remains a significant concern, with outbreaks linked to poor sanitation and limited access to healthcare services. Efforts to improve diagnostic infrastructure are underway to address these challenges.
5. Latin America
Countries like Brazil and Mexico are experiencing an uptick in HEV cases, attributed to urbanization and changes in dietary habits. The demand for diagnostic tests is rising, driven by increased awareness and healthcare investments. Rapid Diagnostic Tests (RDTs) are gaining popularity due to their ease of use and suitability for remote areas .
Explore More:
https://www.polarismarketresearch.com/industry-analysis/hepatitis-e-diagnostic-tests-market
Market Trends
-
Advancements in Diagnostic Technologies: The development of automated serology tests, such as Roche’s Elecsys Anti-HEV IgM and IgG immunoassays, has enhanced diagnostic accuracy and efficiency .
-
Integration of Artificial Intelligence: AI-based solutions are being incorporated into diagnostic workflows to improve test interpretation and reduce human error.
-
Point-of-Care Testing: There is a growing emphasis on developing rapid diagnostic kits that can be used at the point of care, facilitating early detection and treatment .
-
Government Initiatives: Governments in endemic regions are implementing policies to improve sanitation, increase public awareness, and enhance diagnostic capabilities to control the spread of HEV.
Conclusion
The Hepatitis E diagnostic tests market is poised for significant growth, driven by technological advancements, increasing disease prevalence, and the rising demand for accessible diagnostic solutions. Regional disparities in disease burden necessitate tailored strategies to enhance diagnostic capabilities and control the spread of HEV. Continued investments in healthcare infrastructure, research, and public health initiatives are essential to address the challenges posed by Hepatitis E globally.
More Trending Latest Reports By Polaris Market Research:
Infectious Disease Diagnostics Market